Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Chubb
AstraZeneca
Deloitte
Citi
Cipla
Express Scripts
US Department of Justice
Teva

Generated: August 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017100

« Back to Dashboard
NDA 017100 describes PRED MILD, which is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. Additional details are available on the PRED MILD profile page.

The generic ingredient in PRED MILD is prednisolone acetate. There are eighty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.

Summary for NDA: 017100

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 017100

Suppliers and Packaging for NDA: 017100

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRED MILD
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC 017100 NDA Allergan, Inc. 11980-174 11980-174-05 1 BOTTLE, DROPPER in 1 CARTON (11980-174-05) > 5 mL in 1 BOTTLE, DROPPER
PRED MILD
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC 017100 NDA Allergan, Inc. 11980-174 11980-174-10 1 BOTTLE, DROPPER in 1 CARTON (11980-174-10) > 10 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OPHTHALMICStrength0.12%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Citi
Express Scripts
UBS
Daiichi Sankyo
Boehringer Ingelheim
Chinese Patent Office
Colorcon
Cerilliant
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot